Behavioral correlates of dopaminergic supersensitivity.
D000818:Animals; D000831:Animals, Newborn; D001058:Apomorphine / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002540:Cerebral Cortex / Q000032:analysis; D003342:Corpus Striatum / Q000032:analysis; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology*; D007031:Hypothalamus / Q000032:analysis; D007980:Levodopa / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009410:Nerve Degeneration; D051381:Rats; D011955:Receptors, Drug; D013239:Stereotyped Behavior / Q000187:drug effects*; D013378:Substantia Nigra / Q000187:drug effects; D014191:Tranylcypromine / Q000494:pharmacology; D014443:Tyrosine / Q000032:analysis
D006892:Hydroxydopamines; D011955:Receptors, Drug; D014191:Tranylcypromine; D014443:Tyrosine; D007980:Levodopa; D001058:Apomorphine; D003913:Dextroamphetamine; D004298:Dopamine